US Patent Issued to ICHIBIKI, NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY on April 1 for "Bacillus bacterium, interleukin-22 production inducing agent, skin barrier function enhancing agent" (Japanese Inventors)

ALEXANDRIA, Va., April 2 -- United States Patent no. 12,263,194, issued on April 1, was assigned to ICHIBIKI Co. LTD. (Nagoya, Japan) and NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Tokyo).

"Bacillus bacterium, interleukin-22 production inducing agent, skin barrier function enhancing agent" was invented by Toshihiko Kumazawa (Toyohashi, Japan), Atsuhisa Nishimura (Toyohashi, Japan), Noriyuki Asai (Toyohashi, Japan) and Takahiro Adachi (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "A Bacillus bacterium that induces the production of interleukin-22 is provided. The Bacillus bacterium that induces the production of interleukin-22."

The patent was filed on March 16, 2023, under A...